Atlas Trials

Neuro/Sacituzumab Govitecan/Breast Brain Metastasis/Glioblastoma/Ph 0

Clinical trial NCT03995706 · COMPLETED

Trial details

NCT number
NCT03995706
Sponsor
The University of Texas Health Science Center at San Antonio
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Glioblastoma
Start date
2019-07-17
Primary completion
2022-06-03
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.